290 related articles for article (PubMed ID: 23251664)
21. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
Roztocil E; Nicholl SM; Davies MG
Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
[TBL] [Abstract][Full Text] [Related]
22. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
[TBL] [Abstract][Full Text] [Related]
23. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
24. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
Göőz M; Göőz P; Luttrell LM; Raymond JR
J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
[TBL] [Abstract][Full Text] [Related]
25. Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.
Sato S; Kamada H; Watanabe T; Tsuji I; Fan J
PLoS One; 2013; 8(1):e54509. PubMed ID: 23349913
[TBL] [Abstract][Full Text] [Related]
26. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
27. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
Seo M; Lee MJ; Heo JH; Lee YI; Kim Y; Kim SY; Lee ES; Juhnn YS
J Biol Chem; 2007 Aug; 282(34):24720-30. PubMed ID: 17548351
[TBL] [Abstract][Full Text] [Related]
28. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts.
Shiomi T; Boudreault F; Padem N; Higashiyama S; Drazen JM; Tschumperlin DJ
Wound Repair Regen; 2011; 19(2):229-40. PubMed ID: 21362091
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
31. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
[TBL] [Abstract][Full Text] [Related]
32. Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities.
Lee DH; Lee MY; Seo Y; Hong HJ; An HJ; Kang JS; Kim HM
Biomaterials; 2018 Jul; 171():34-45. PubMed ID: 29679794
[TBL] [Abstract][Full Text] [Related]
33. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
34. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.
Hatakeyama H; Cheng H; Wirth P; Counsell A; Marcrom SR; Wood CB; Pohlmann PR; Gilbert J; Murphy B; Yarbrough WG; Wheeler DL; Harari PM; Guo Y; Shyr Y; Slebos RJ; Chung CH
PLoS One; 2010 Sep; 5(9):e12702. PubMed ID: 20856931
[TBL] [Abstract][Full Text] [Related]
35. The anti-EGFR monoclonal antibody blocks cisplatin-induced activation of EGFR signaling mediated by HB-EGF.
Yoshida T; Okamoto I; Iwasa T; Fukuoka M; Nakagawa K
FEBS Lett; 2008 Dec; 582(30):4125-30. PubMed ID: 19027738
[TBL] [Abstract][Full Text] [Related]
36. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Xu KP; Ding Y; Ling J; Dong Z; Yu FS
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
[TBL] [Abstract][Full Text] [Related]
37. PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib.
Ueda S; Basaki Y; Yoshie M; Ogawa K; Sakisaka S; Kuwano M; Ono M
Cancer Res; 2006 May; 66(10):5346-53. PubMed ID: 16707461
[TBL] [Abstract][Full Text] [Related]
38. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
Reznik TE; Sang Y; Ma Y; Abounader R; Rosen EM; Xia S; Laterra J
Mol Cancer Res; 2008 Jan; 6(1):139-50. PubMed ID: 18234969
[TBL] [Abstract][Full Text] [Related]
39. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
40. An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.
Mahtouk K; Jourdan M; De Vos J; Hertogh C; Fiol G; Jourdan E; Rossi JF; Klein B
Blood; 2004 Mar; 103(5):1829-37. PubMed ID: 14576062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]